80
Participants
Start Date
August 1, 2022
Primary Completion Date
July 15, 2023
Study Completion Date
August 1, 2023
Group 1
Salbutamol inhaler, Omron® CompAIR Pro NE-C900 Compressor Nebulizer (Omron Healthcare Co., Ltd., Kyoto, Japan) was used in Group 1
Group 2
Salbutamol inhaler, Mesh nebulizer (Aerogen Solo®, Aerogen Ltd, Galway, Ireland) was used in Group 2
UHS Haseki Training and Research Hospital, Istanbul
Berker Okay
OTHER